Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment


Phase 4 Results N/A

Summary of Purpose

The primary objective is to compare the safety of clopidogrel 50mg and 75mg in cerebral infarction with respect to incidence of bleeding adverse events.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 February 2010.

1 Sep 2006 10 Oct 2006 1 Dec 2008 1 Dec 2008 1 Feb 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available